Crit Rev Oral Biol Med 2004, 15:308–320.PubMedCrossRef 39. Koch S, Hufnagel M, Theilacker C, Huebner J: selleck chemicals llc Enterococcal infections: host response, therapeutic, and prophylactic possibilities. Vaccine 2004, 22:822–830.PubMedCrossRef 40. Sartingen S, Rozdzinski E, Muscholl-Silberhorn A, Marre R: Aggregation substance increases adherence and internalization, but not translocation, of Enterococcus faecalis through different intestinal epithelial cells in vitro. Infect Immun 2000, 68:6044–6047.PubMedCrossRef
41. Kreft B, Marre R, Schramm U, Wirth R: Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells. Infect Immun 1992, 60:25–30.PubMed 42. Sussmuth SD, Muscholl-Silberhorn A, Wirth Entinostat price R, Susa M, Marre R, Rozdzinski E: Aggregation substance promotes adherence, phagocytosis, and intracellular survival of Enterococcus faecalis within human macrophages and suppresses respiratory burst. Infect Immun 2000, 68:4900–4906.PubMedCrossRef 43. Archimbaud C, Shankar N, Forestier C, Baghdayan A, Gilmore MS, Charbonné F, Jolya B: In vitro adhesive properties and virulence factors of
Enterococcus faecalis strains. Research in Microbiology 2002, 153:75–80.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions BK was the primary author of the manuscript, assisted in samples collection, molecular identification of oral Enterococci, antimicrobial
susceptibility, PI3K inhibitor biofilms and adherence assay. TZ was the person contributed in biofilms assay and helped in the writing of the manuscript. Nintedanib (BIBF 1120) KM was the person who participated in data acquisition and contributed in writing the manuscript. HH helped in samples collection, designed and participated in the writing of the manuscript. AB provided funding, supervised the study, and helped to finalize the manuscript. All authors read and approved the final version of the manuscript. Financial competing interests Ministère Tunisien de l’Enseignement Supérieur, de la Recherche Scientifique” through the ”Laboratoire d’Analyses, Traitement et Valorisation des Polluants de l’Environnement et des Produits, Faculté de Pharmacie, rue Avicenne 5000 Monastir (Tunisie).”
“Background Lactic acid bacteria is now widely used as probiont for its multifactorial benefits to humans as well as to organisms like fish, poultry and other live stock. In addition to various sources of isolation [[1–3]], several recent studies have described the isolation and characterisation of probiotic microorganisms from traditionally fermented sources like Dongchimi, Kimchi, Meju, and Doenjang [4], and Kallappam batter, Koozh and Mor Kuzhambu [5]. Likewise, traditional Ayurvedic medicines might serve as a source and a reservoir of potential probiotic microbes. Nevertheless, there are very little efforts made in exploration of probionts from ayurvedic fermented sources.